These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29555627)

  • 21. Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development.
    Green JL; Moon RW; Whalley D; Bowyer PW; Wallace C; Rochani A; Nageshan RK; Howell SA; Grainger M; Jones HM; Ansell KH; Chapman TM; Taylor DL; Osborne SA; Baker DA; Tatu U; Holder AA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1464-75. PubMed ID: 26711771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.
    Moine E; Dimier-Poisson I; Enguehard-Gueiffier C; Logé C; Pénichon M; Moiré N; Delehouzé C; Foll-Josselin B; Ruchaud S; Bach S; Gueiffier A; Debierre-Grockiego F; Denevault-Sabourin C
    Eur J Med Chem; 2015 Nov; 105():80-105. PubMed ID: 26479029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
    Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
    Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.
    Ojo KK; Larson ET; Keyloun KR; Castaneda LJ; Derocher AE; Inampudi KK; Kim JE; Arakaki TL; Murphy RC; Zhang L; Napuli AJ; Maly DJ; Verlinde CL; Buckner FS; Parsons M; Hol WG; Merritt EA; Van Voorhis WC
    Nat Struct Mol Biol; 2010 May; 17(5):602-7. PubMed ID: 20436472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of dihydroorotate dehydrogenase as a relevant drug target for 1-hydroxyquinolones in Toxoplasma gondii.
    Hegewald J; Gross U; Bohne W
    Mol Biochem Parasitol; 2013 Jul; 190(1):6-15. PubMed ID: 23747278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii.
    Lourido S; Zhang C; Lopez MS; Tang K; Barks J; Wang Q; Wildman SA; Shokat KM; Sibley LD
    J Med Chem; 2013 Apr; 56(7):3068-77. PubMed ID: 23470217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites.
    Jiménez-Meléndez A; Ojo KK; Wallace AM; Smith TR; Hemphill A; Balmer V; Regidor-Cerrillo J; Ortega-Mora LM; Hehl AB; Fan E; Maly DJ; Van Voorhis WC; Álvarez-García G
    Int J Parasitol; 2017 Oct; 47(12):811-821. PubMed ID: 28899692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.
    Vidadala RS; Rivas KL; Ojo KK; Hulverson MA; Zambriski JA; Bruzual I; Schultz TL; Huang W; Zhang Z; Scheele S; DeRocher AE; Choi R; Barrett LK; Siddaramaiah LK; Hol WG; Fan E; Merritt EA; Parsons M; Freiberg G; Marsh K; Kempf DJ; Carruthers VB; Isoherranen N; Doggett JS; Van Voorhis WC; Maly DJ
    J Med Chem; 2016 Jul; 59(13):6531-46. PubMed ID: 27309760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
    Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of a Toxoplasma gondii calcium calmodulin-dependent protein kinase homolog.
    Kato K; Sugi T; Takemae H; Takano R; Gong H; Ishiwa A; Horimoto T; Akashi H
    Parasit Vectors; 2016 Jul; 9(1):405. PubMed ID: 27444499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effects and Mechanism of ATM Kinase Inhibitors in
    Xue Y; Ying Z; Wang F; Yin M; Pei Y; Liu J; Liu Q
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000057
    [No Abstract]   [Full Text] [Related]  

  • 32. Forward genetic screening identifies a small molecule that blocks Toxoplasma gondii growth by inhibiting both host- and parasite-encoded kinases.
    Brown KM; Suvorova E; Farrell A; McLain A; Dittmar A; Wiley GB; Marth G; Gaffney PM; Gubbels MJ; White M; Blader IJ
    PLoS Pathog; 2014 Jun; 10(6):e1004180. PubMed ID: 24945800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
    Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
    J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
    Ma C; Tran J; Gu F; Ochoa R; Li C; Sept D; Werbovetz K; Morrissette N
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1453-60. PubMed ID: 20145086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single mutation in the gatekeeper residue in TgMAPKL-1 restores the inhibitory effect of a bumped kinase inhibitor on the cell cycle.
    Sugi T; Kawazu S; Horimoto T; Kato K
    Int J Parasitol Drugs Drug Resist; 2015 Apr; 5(1):1-8. PubMed ID: 25941623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxoplasma DJ-1 Regulates Organelle Secretion by a Direct Interaction with Calcium-Dependent Protein Kinase 1.
    Child MA; Garland M; Foe I; Madzelan P; Treeck M; van der Linden WA; Oresic Bender K; Weerapana E; Wilson MA; Boothroyd JC; Reese ML; Bogyo M
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.
    Müller J; Aguado-Martínez A; Balmer V; Maly DJ; Fan E; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Plasmodium falciparum CDPK1 by conditional expression of its J-domain demonstrates a key role in schizont development.
    Azevedo MF; Sanders PR; Krejany E; Nie CQ; Fu P; Bach LA; Wunderlich G; Crabb BS; Gilson PR
    Biochem J; 2013 Jun; 452(3):433-41. PubMed ID: 23548171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photoswitchable Inhibitors to Optically Control Specific Kinase Activity.
    Aguirre T; Teichmann E; Römpp FQ; Vivier R; Bryant C; Hulverson MA; Van Voorhis WC; Ojo KK; Doggett JS; Fiedler D; Hecht S
    ACS Chem Biol; 2023 Jun; 18(6):1378-1387. PubMed ID: 37167414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent and selective inhibitors of CDPK1 from
    Zhang Z; Ojo KK; Vidadala R; Huang W; Geiger JA; Scheele S; Choi R; Reid MC; Keyloun KR; Rivas K; Siddaramaiah LK; Comess KM; Robinson KP; Merta PJ; Kifle L; Hol WG; Parsons M; Merritt EA; Maly DJ; Verlinde CL; Van Voorhis WC; Fan E
    ACS Med Chem Lett; 2014 Jan; 5(1):40-44. PubMed ID: 24494061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.